Hamps Bio Reports Turnaround Performance in H1 FY27 Financial Results
Hamps Bio Ltd · Outcome · 07 Nov 2026, 1:33 am
Hamps Bio Reports Turnaround Performance in H1 FY27 Financial Results Hamps Bio Limited reported standalone revenue from operations of ₹593.89 lakhs for the half year ended 30th Sep'26, up 48.79% YoY from ₹399.15 lakhs in 30th Sep'25. Standalone net profit turned around to ₹19.76 lakhs from a loss of ₹19.55 lakhs YoY. Consolidated revenue reached ₹730.76 lakhs with a net profit of ₹20.44 lakhs and EPS of ₹0.23. The freeze-dried products division contributed ₹552.86 lakhs to consolidated segment revenue, while pharma products generated ₹216.22 lakhs. All IPO proceeds of ₹622.20 lakhs stand fully utilized.
Original exchange filing (PDF)
More announcements from Hamps Bio Ltd
- Unaudited financial result for half year ended 30.09.2026 is attached herewith. · 07 Nov 2026
- Hamps Bio Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve the Unaudited Standalone And Consolidated .... · 06 Nov 2026
- The voting results along with the Scrutinizer report for 19th AGM is attached herewith. · 11 Sept 2026
- Board Meeting Outcome for Board Meeting held on 9th September, 2026. · 09 Sept 2026
- The proceedings of 19th AGM is attached herewith. · 09 Sept 2026
- We have attached herewith the annual report for the financial year 2025-26. · 18 Aug 2026
- We have attached herewith the Annual General Meeting notice for the year 2025-26. · 18 Aug 2026
- Outcome of Board Meeting. · 13 Aug 2026
